Mumps outbreak in the Republic of Moldova, 2007-2008

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 703-706

  Schwarz, Norbert G ^a,b,c   Bernard, Helen ^d,e,f   Melnic, Anatolie ^g   Bucov, Victoria ^g   Caterinciuc, Natalia ^g   An Der Heiden, Matthias ^d   Andrews, Nick ^h   Pebody, Richard ^h   Aidyralieva, Chinara ⁱ   Hahné, Susan ^j,k  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b European Programme for Intervention Epidemiology Training EPIET   (Sweden)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

^e Postgraduate Training for Applied Epidemiology PAE   (Germany)

^f Bavarian Health and Food Safety Authority LGL   (Germany)

^g National Scientific Applied Centre for Preventive Medicine   (Moldova)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^k NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

disease outbreak; measles mumps rubella vaccine; mumps; mumps vaccine; vaccine effectiveness; vaccine failure

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG EFFICACY; EPIDEMIC; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MOLDOVA; MUMPS; MUMPS VIRUS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCHOOL CHILD; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN; AGE DISTRIBUTION; CLASSIFICATION; COHORT ANALYSIS; GENETICS; INFANT; ISOLATION AND PURIFICATION; PROCEDURES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; MOLDOVA; MUMPS; MUMPS VACCINE; MUMPS VIRUS; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 77955175063     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d743df     Document Type: Article

References (28)

1. Edmunds WJ, Gay NJ, Kretzschmar M, et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect. 2000;125:635-650.
2. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77:3-14.
3. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358:1580-1589.
4. Atrasheuskaya AV, Kulak MV, Rubin S, et al. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004. Clin Microbiol Infect. 2007;13:670-676.
5. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371:932-944.
6. Caterinciuc N. Caracteristica generala a proceului epidemic la oreion in RM in diferite perioade. Bul ASM. 2008;3:129-135.
7. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993;22:742-746.
8. Statacorp. STATA 10 Statistical Data Analysis Software. Lakeway Drive College Station, Texas: 2008.
9. Jin L, Feng Y, Parry R, et al. Real-time PCR and its application to mumps rapid diagnosis. J Med Virol. 2007;79:1761-1767.
10. Jin L, Brown DW, Litton PA, et al. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis. 2004;189:1001-1008.
11. Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis. 1994;169:77-82.
12. Vandermeulen C, Roelants M, Vermoere M, et al. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine. 2004; 22:2713-2716.
13. Broliden K, Abreu ER, Arneborn M, et al. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine. 1998;16:323-327.
14. Date AA, Kyaw MH, Rue AM, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197:1662-1668.
15. Davidkin I, Jokinen S, Broman M, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950-956.
16. Miller E, Hill A, Morgan-Capner P, et al. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine. 1995;13:799-802.
17. Jokinen S, Osterlund P, Julkunen I, et al. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis. 2007;196:861-867.
18. Cheek JE, Baron R, Atlas H, et al. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med. 1995;149:774-778.
19. Wharton M, Cochi SL, Hutcheson RH, et al. A large outbreak of mumps in the postvaccine era. J Infect Dis. 1988;158:1253-1260.
20. Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12-17.
21. Schaffzin JK, Pollock L, Schulte C, et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics. 2007;120:e862-e868.
22. Rubin S, Mauldin J, Chumakov K, et al. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine. 2006;24:2662-2668.
23. Nojd J, Tecle T, Samuelsson A, et al. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine. 2001;19:1727-1731.
24. Rubin SA, Qi L, Audet SA, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198:508-515.
25. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46:1172-1180.
26. Polgreen PM, Bohnett LC, Cavanaugh JE, et al. The duration of mumps virus shedding after the onset of symptoms. Clin Infect Dis. 2008;46: 1447-1449.
27. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47:1458-1467.
28. WHO (position paper on mumps vaccines). Mumps virus and vaccines. Wkly Epid Rec. 2007;82:51-60.